Targeted Perivascular Delivery of Solutions
Ablative Solutions has developed the Peregrine SystemTM Infusion Catheter, a new catheter-based approach for percutaneous delivery of diagnostic and therapeutic agents into the area surrounding the peripheral blood vessels, called the perivascular space. This region is dynamic and consists of sympathetic nerves, lymphatic vessels, and a rich diversity of cells that can influence blood vessel function, repair and disease.
Upcoming Events
CRT
March 2-5, 2019
Washington, DC
Peregrine SystemTM Infusion Catheter
The Peregrine SystemTM Infusion Catheter uses an intravascular delivery approach to deliver diagnostic and therapeutic agents to the area surrounding blood vessels.
CMI, 2013 All Rights Reserved
Clinical Research
Committed to robust science, Ablative Solutions is currently conducting a Phase 2 global clinical trial, TARGET BP I, for treatment of hypertension with combination drug/device therapy using the Peregrine SystemTM Kit.
Investor Relations
FDA allows Ablative Solutions to initiate its Phase 2 TARGET BP I trial of combination drug/device therapy for hypertension under its IND.